Derbend Asset Management’s AbbVie ABBV Stock Holding History

Derbend Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$1.04M	Buy	5,738 +1,265	+28%	+$218K	0.51%	40
2023 Q4	$693K	Buy	4,473 +129	+3%	+$18.8K	0.4%	49
2023 Q3	$648K	Buy	4,344 +126	+3%	+$18.5K	0.44%	44
2023 Q2	$568K	Buy	4,218 +31	+0.7%	+$4.55K	0.38%	38
2023 Q1	$667K	Buy	4,187 +30	+0.7%	+$4.59K	0.5%	32
2022 Q4	$672K	Sell	4,157 -199	-5%	-$30.5K	0.54%	38
2022 Q3	$585K	Buy	4,356 +5	+0.1%	+$717	0.47%	41
2022 Q2	$666K	Sell	4,351 -4,456	-51%	-$681K	0.56%	36
2022 Q1	$1.19M	Hold	8,807	–	–	1.16%	27
2021 Q4	$1.19M	Sell	8,807 -425	-5%	-$50.2K	1.16%	27
2021 Q3	$996K	Sell	9,232 -806	-8%	-$92.1K	0.94%	37
2021 Q2	$1.13M	Buy	+10,038	New	+$1.13M	1.05%	33

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Derbend Asset Management's ABBV Position: Q1 2024 in Review

Derbend Asset Management increased its AbbVie (ABBV) stake by 28% in Q1 2024, buying an estimated $218K and bringing the position to 5,738 shares worth $1.04M. The position accounts for 0.51% of the portfolio, ranked #40.

Derbend Asset Management first reported a position in ABBV in Q2 2021 and has held it in 12 quarters since. The position peaked at $1.19M in Q1 2022. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

Derbend Asset Management held 5,738 shares of AbbVie worth $1.04M as of Q1 2024.
Derbend Asset Management bought 1,265 AbbVie shares in Q1 2024, an estimated $218K.
AbbVie made up 0.51% of Derbend Asset Management's portfolio in Q1 2024, its #40 holding.
Derbend Asset Management first reported a position in AbbVie in Q2 2021 and has held it in 12 quarters since.
Derbend Asset Management's AbbVie position peaked at $1.19M in Q1 2022.
3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Derbend Asset Management's 13F filing for Q1 2024, filed 30 Apr 2024.